Related Experiment Videos

Murine cytomegalovirus

Immunobiology
|January 1, 1987
PubMed

Insights

Murine cytomegalovirus (MCMV) infection impairs humoral immunity, particularly T-dependent responses, with varying effects on antibody production and B cell memory in BALB/c and C57BL/6 mice.

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Murine cytomegalovirus (MCMV) is a significant pathogen impacting host immune responses.
  • Understanding how viral infections affect adaptive immunity, specifically humoral responses, is crucial for managing disease.
  • Different mouse strains exhibit distinct immune susceptibilities and responses to pathogens.

Purpose of the Study:

  • To investigate the impact of MCMV infection on humoral immune responses in BALB/c and C57BL/6 mice.
  • To compare the effects of MCMV on T-dependent and T-independent antibody production.
  • To assess the influence of MCMV on B cell memory formation.

Main Methods:

  • BALB/c and C57BL/6 mice were infected with MCMV.
  • Animals were immunized with T-dependent (SRBC), T-independent (TNP-Ficoll), and poliovirus antigens at different time points post-infection (day 4 or 12).
  • Humoral immune responses, including antibody production and plaque-forming cells, were measured.

Main Results:

  • Adverse effects on humoral immunity were observed primarily in mice infected on day 4.
  • Anti-SRBC antibody formation was significantly reduced in both mouse strains.
  • Reduced plaque-forming cells for TNP-Ficoll were noted only in BALB/c mice, while poliovirus antibody levels were depressed in both strains, with BALB/c showing a greater reduction.
  • MCMV infection affected anti-SRBC B cell memory.

Conclusions:

  • MCMV infection differentially impacts T-dependent and T-independent humoral immune responses.
  • Mouse strain background (BALB/c vs. C57BL/6) influences the susceptibility to MCMV-induced immunomodulation.
  • The timing of antigen exposure relative to MCMV infection is critical in determining the severity of immune impairment.

Related Concept Videos